313 related articles for article (PubMed ID: 31653827)
21. Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.
Halder RC; Tran C; Prasad P; Wang J; Nallapothula D; Ishikawa T; Wang M; Zajonc DM; Singh RR
Eur J Immunol; 2019 Feb; 49(2):242-254. PubMed ID: 30508304
[TBL] [Abstract][Full Text] [Related]
22. Autoreactivity to Sulfatide by Human Invariant NKT Cells.
Stax AM; Tuengel J; Girardi E; Kitano N; Allan LL; Liu V; Zheng D; Panenka WJ; Guillaume J; Wong CH; van Calenbergh S; Zajonc DM; van den Elzen P
J Immunol; 2017 Jul; 199(1):97-106. PubMed ID: 28526683
[TBL] [Abstract][Full Text] [Related]
23. Activation of invariant natural killer T cells impedes liver regeneration by way of both IFN-γ- and IL-4-dependent mechanisms.
Yin S; Wang H; Bertola A; Feng D; Xu MJ; Wang Y; Gao B
Hepatology; 2014 Oct; 60(4):1356-66. PubMed ID: 24623351
[TBL] [Abstract][Full Text] [Related]
24. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
[TBL] [Abstract][Full Text] [Related]
25. CD1d-dependent endogenous and exogenous lipid antigen presentation.
McEwen-Smith RM; Salio M; Cerundolo V
Curr Opin Immunol; 2015 Jun; 34():116-25. PubMed ID: 25805574
[TBL] [Abstract][Full Text] [Related]
26. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
Cheng L; Ueno A; Cho S; Im JS; Golby S; Hou S; Porcelli SA; Yang Y
J Immunol; 2007 Mar; 178(5):2755-62. PubMed ID: 17312118
[TBL] [Abstract][Full Text] [Related]
27. CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis.
Schneiders FL; Prodöhl J; Ruben JM; O'Toole T; Scheper RJ; Bonneville M; Scotet E; Verheul HM; de Gruijl TD; van der Vliet HJ
Cancer Immunol Res; 2014 Aug; 2(8):732-40. PubMed ID: 24934445
[TBL] [Abstract][Full Text] [Related]
28. Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.
Brennan PJ; Cheng TY; Pellicci DG; Watts GFM; Veerapen N; Young DC; Rossjohn J; Besra GS; Godfrey DI; Brenner MB; Moody DB
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8348-8353. PubMed ID: 28716901
[TBL] [Abstract][Full Text] [Related]
29. Graphene oxide polarizes iNKT cells for production of TGFβ and attenuates inflammation in an iNKT cell-mediated sepsis model.
Lee SW; Park HJ; Van Kaer L; Hong S; Hong S
Sci Rep; 2018 Jul; 8(1):10081. PubMed ID: 29973666
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.
Fox LM; Miksanek J; May NA; Scharf L; Lockridge JL; Veerapen N; Besra GS; Adams EJ; Hudson AW; Gumperz JE
Cancer Immun; 2013; 13():9. PubMed ID: 23885215
[TBL] [Abstract][Full Text] [Related]
31. A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
Birkholz AM; Girardi E; Wingender G; Khurana A; Wang J; Zhao M; Zahner S; Illarionov PA; Wen X; Li M; Yuan W; Porcelli SA; Besra GS; Zajonc DM; Kronenberg M
J Immunol; 2015 Aug; 195(3):924-33. PubMed ID: 26078271
[TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
[TBL] [Abstract][Full Text] [Related]
33. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
34. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
[TBL] [Abstract][Full Text] [Related]
35. The mechanism of splenic invariant NKT cell activation dictates localization in vivo.
King IL; Amiel E; Tighe M; Mohrs K; Veerapen N; Besra G; Mohrs M; Leadbetter EA
J Immunol; 2013 Jul; 191(2):572-82. PubMed ID: 23785119
[TBL] [Abstract][Full Text] [Related]
36. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs.
Tatituri RV; Watts GF; Bhowruth V; Barton N; Rothchild A; Hsu FF; Almeida CF; Cox LR; Eggeling L; Cardell S; Rossjohn J; Godfrey DI; Behar SM; Besra GS; Brenner MB; Brigl M
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1827-32. PubMed ID: 23307809
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
[TBL] [Abstract][Full Text] [Related]
38. The GM2 ganglioside inhibits iNKT cell responses in a CD1d-dependent manner.
Pereira CS; Ribeiro H; Pérez-Cabezas B; Cardoso MT; Alegrete N; Gaspar A; Leão-Teles E; Macedo MF
Mol Genet Metab; 2018 Sep; 125(1-2):161-167. PubMed ID: 30030044
[TBL] [Abstract][Full Text] [Related]
39. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.
Oleinika K; Rosser EC; Matei DE; Nistala K; Bosma A; Drozdov I; Mauri C
Nat Commun; 2018 Feb; 9(1):684. PubMed ID: 29449556
[TBL] [Abstract][Full Text] [Related]
40. Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.
Horst D; Geerdink RJ; Gram AM; Stoppelenburg AJ; Ressing ME
Viruses; 2012 Oct; 4(10):2379-99. PubMed ID: 23202469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
